References
- De Botton S, Dombret H, Sanz M, San Miguel J, Caillot D, Zittoun R, et al. Incidence, clinical features and outcome of all-trans retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukaemia. Blood 1998; 92: 2712–2718
- Tallman M S, Andersen J W, Schiffer C A, Appelbaum F R, Feusner J H, Ogden A, et al. Clinical description of 44 patients with acute promyelocytic leukaemia who developed the retinoic acid syndrome. Blood 2000; 95: 90–95
- Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, et al. Molecular remission in PML/RARAa positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto. Blood 1997; 90: 1014–1021
- Di Noto R, Lo Pardo C, Schiavone E M, Ferrara F, Manzo C, Vacca C, et al. All-trans retinoic acid and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma 1996; 21: 201–209
- Vahdat L, Maslak P, Miller W H, Eardley A, Heller G, Scheinberg D A, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukaemia: impact of leukocytosis, low-dose chemotherapy, PML/RARa isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 1994; 84: 3843–3849
- Claxton D F, Reading C L, Nagarajan L, Tsujimoto Y, Andersson B S, Estey E, et al. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukaemia. Blood 1992; 80: 582–586
- Biondi A, Luciano A, Bassan R, Mininni D, Specchia G, Lanzi E, et al. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. Leukemia 1995; 9: 1461–1466
- Gasser C, Gautier E, Steck A, Siebenmann R E, Oechslin R. Hemolytic uremic syndrome: bilateral kidney cortex necrosis in acute acquired hemolytic anemia. Schweiz Med Wochenschr 1955; 85: 905–909
- Allford S L, Hunt B J, Rose P, Machin S J, Haemostasis and Thrombosis Task Force British Committee for Standards in Haematology. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003; 120: 556–573
- Gordon L I, Kwaan H C. Cancer- and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 1997; 34: 140–147
- Bell W R, Braine H G, Ness P M, Kickler T S. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991; 325: 398–403
- Rock G A, Shumak K H, Buskard N A, Blanchette V S, Kelton J G, Nair R C, Spasoff R A. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991; 325: 393–397